Cargando…

A Case of Metaplastic Squamous Cell Carcinoma of the Breast that Showed a Pathological Complete Response After Neoadjuvant Chemotherapy with Weekly Paclitaxel

Patient: Female, 40-year-old Final Diagnosis: Squamous cell carcinoma of the breast Symptoms: A palpable tumor of the right breast Medication: — Clinical Procedure: Core needle biopsy Specialty: Oncology OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: Primary squamous cell carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noro, Aya, Ishitobi, Makoto, Hanamura, Noriko, Kashikura, Yumi, Yamashita, Masako, Kozuka, Yuji, Saito, Kanako, Mizuno, Toshiro, Ogawa, Tomoko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765086/ https://www.ncbi.nlm.nih.gov/pubmed/35017459 http://dx.doi.org/10.12659/AJCR.935035

Ejemplares similares

Oncoplastic Technique Combining an Adipofascial Flap with an Extended Glandular Flap for the Breast-Conserving Reconstruction of Small Dense Breasts
por: Ogawa, Tomoko, et al.
Publicado: (2012)

Abdominal Advancement Flap as Oncoplastic Breast Conservation: Report of Seven Cases and Their Cosmetic Results
por: Ogawa, Tomoko, et al.
Publicado: (2013)

Breast-Volume Displacement Using an Extended Glandular Flap for Small Dense Breasts
por: Ogawa, Tomoko, et al.
Publicado: (2011)

Cosmetic Evaluation Methods Adapted to Asian Patients after Breast-Conserving Surgery and Examination of the Necessarily Elements for Cosmetic Evaluation
por: Nohara, Yuki, et al.
Publicado: (2015)

CD204-positive macrophages accumulate in breast cancer tumors with high levels of infiltrating lymphocytes and programmed death ligand-1 expression
por: Nagano, Mayuko, et al.
Publicado: (2021)

Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
por: Wong, Willard, et al.
Publicado: (2021)

Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin
por: Dessai, S. B., et al.
Publicado: (2016)

Complete Response of Chemo-Refractory Metastatic Metaplastic Breast Cancer to Paclitaxel-Immunotherapy Combination
por: Al Sayed, Adher D., et al.
Publicado: (2019)

Significant efficacy of paclitaxel plus carboplatin (TP) as a neoadjuvant regimen for metaplastic squamous cell carcinoma of the breast: a rare case report and literature review
por: Chen, Baolin, et al.
Publicado: (2022)

Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer
por: Kim, Yoo-Na, et al.
Publicado: (2019)

Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer
por: Li, Jing, et al.
Publicado: (2023)

Caffeine-Induced Suppression of GABAergic Inhibition and Calcium-Independent Metaplasticity
por: Isokawa, Masako
Publicado: (2016)

Weekly vs Every-3-Week Carboplatin with Weekly Paclitaxel in Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Retrospective Analysis
por: Landry, Kara K, et al.
Publicado: (2022)

HER2-Positive Metaplastic Breast Cancer with Resistance to Neoadjuvant Chemotherapy: Case Report
por: Tateishi, Kaho, et al.
Publicado: (2023)

Airway basal cells show regionally distinct potential to undergo metaplastic differentiation
por: Zhou, Yizhuo, et al.
Publicado: (2022)

Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer
por: Asaduzzaman, Muhammad, et al.
Publicado: (2017)

Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study
por: van Meerten, E, et al.
Publicado: (2006)

Clinical outcomes of neoadjuvant chemotherapy for patients with breast cancer: Tri-weekly nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide: a retrospective observational study
por: Shizuku, Masato, et al.
Publicado: (2020)

Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer
por: Foldi, Julia, et al.
Publicado: (2021)

Neurogranin Regulates Metaplasticity
por: Zhong, Ling, et al.
Publicado: (2020)

Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma
por: Lien, Huang-Chun, et al.
Publicado: (2023)

Metaplastic carcinoma of the breast and BRCA1 germline mutation: a case report and review
por: Yamashita, Michiko, et al.
Publicado: (2021)

Neoadjuvant nab-paclitaxel in the treatment of breast cancer
por: Ueno, Naoto T., et al.
Publicado: (2016)

First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer
por: Oda, Hiroyasu, et al.
Publicado: (2019)

A case report of locally advanced triple negative breast cancer showing pathological complete response to weekly paclitaxel with bevacizumab treatment following disease progression during anthracycline-based neoadjuvant chemotherapy
por: Shigematsu, Hideo, et al.
Publicado: (2017)

The metaplastic mosaic of Barrett’s oesophagus
por: Biswas, Sujata, et al.
Publicado: (2018)

Synaptic Plasticity, Metaplasticity and Depression
por: Vose, Linnea R., et al.
Publicado: (2017)

Value of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin
por: Wang, Ruo-Xi, et al.
Publicado: (2016)

Weekly paclitaxel and cisplatin as neoadjuvant chemotherapy with locally advanced breast cancer: a prospective, single arm, phase II study
por: Zhou, Liheng, et al.
Publicado: (2017)

Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer
por: Foldi, Julia, et al.
Publicado: (2022)

Adenomatous Polyposis Coli loss controls cell cycle regulators and response to paclitaxel in MDA-MB-157 metaplastic breast cancer cells
por: Astarita, Emily M., et al.
Publicado: (2021)

Phase II trial of weekly nab-paclitaxel and carboplatin treatment with or without trastuzumab as nonanthracycline neoadjuvant chemotherapy for locally advanced breast cancer
por: Huang, Liang, et al.
Publicado: (2015)

Safety and efficacy of weekly versus three-weekly paclitaxel plus platinum neoadjuvant chemotherapy in patients with locally advanced squamous cell head and neck carcinoma: A pilot study
por: Mathur, Akash, et al.
Publicado: (2018)

Binding of αvβ1 and αvβ6 integrins to tenascin-C induces epithelial–mesenchymal transition-like change of breast cancer cells
por: Katoh, D, et al.
Publicado: (2013)

Metaplastic Breast Cancer: To Radiate or Not to Radiate?
por: Tseng, Warren H., et al.
Publicado: (2010)

Treatment Options for Metaplastic Breast Cancer
por: Shah, Dhruvil R., et al.
Publicado: (2012)

Structural Plasticity Can Produce Metaplasticity
por: Kalantzis, Georgios, et al.
Publicado: (2009)

Totally Ossified Metaplastic Spinal Meningioma
por: Ju, Chang Il, et al.
Publicado: (2013)

Metaplastic Thymoma: Report of 4 Cases
por: Kang, Guhyun, et al.
Publicado: (2012)

Models of Metaplasticity: A Review of Concepts
por: Yger, Pierre, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tvo6bn43m8b0c98021mv218rcj